CN Patent

CN105708819A — 医药制剂

Assigned to Array Biopharma Inc · Expires 2016-06-29 · 10y expired

What this patent protects

本发明涉及(S)甲基(1((4(3(5氯2氟3(甲基磺酰氨基)苯基)1异丙基1H吡唑4基)嘧啶2基)氨基)丙2基)氨基甲酸酯(化合物A)的固体口服医药制剂，和这些制剂于治疗增殖性疾病，例如实体肿瘤疾病，的用途。

USPTO Abstract

本发明涉及(S)甲基(1((4(3(5氯2氟3(甲基磺酰氨基)苯基)1异丙基1H吡唑4基)嘧啶2基)氨基)丙2基)氨基甲酸酯(化合物A)的固体口服医药制剂，和这些制剂于治疗增殖性疾病，例如实体肿瘤疾病，的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN105708819A
Jurisdiction
CN
Classification
—
Expires
2016-06-29
Drug substance claim
No
Drug product claim
No
Assignee
Array Biopharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.